GCNT4 mediates the formation of core2 in O-GalNAc glycosylation, which stabilizes the normal conformation of cell surface mucins and blocks abnormal glycosylation ligand receptor interactions between tumor cells and immune cells in the microenvironment [37,38]. Here, GCNT4 is linked to neoplasm.